2,746 results on '"Pieske, Burkert"'
Search Results
102. Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial.
103. Abstract 13829: Index Event, Clinical Outcomes and Response to Vericiguat in the Victoria Trial
104. Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF
105. Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome: Insights From the International Takotsubo Registry
106. β1-Adrenoreceptor Autoantibodies in Heart Failure: Physiology and Therapeutic Implications
107. SGK1 induces vascular smooth muscle cell calcification through NF-[kappa]B signaling
108. Expert opinion paper on atrial fibrillation detection after ischemic stroke
109. Renal sympathetic denervation restores aortic distensibility in patients with resistant hypertension: data from a multi-center trial
110. Early detection of cardiac alterations by left atrial strain in patients with risk for cardiac abnormalities with preserved left ventricular systolic and diastolic function
111. Fatty metaplasia quantification and impact on regional myocardial function as assessed by advanced cardiac MR imaging
112. Acute Infections and Inflammatory Biomarkers in Patients with Acute Pulmonary Embolism
113. Pitfalls of mitral regurgitation assessment in the presence of mitral valve prolapse
114. Left-ventricular unloading in extracorporeal cardiopulmonary resuscitation due to acute myocardial infarction – A multicenter study
115. Biventricular Cardiac Power Reserve in Heart Failure and Preserved Ejection Fraction
116. Mechanistic assessment and ablation of left ventricular assist device related ventricular tachycardia in patients with severe heart failure
117. Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials
118. Management of Worsening Heart Failure With Reduced Ejection Fraction:JACC Focus Seminar 3/3
119. NT-proBNP and diastolic left ventricular function in patients with Marfan syndrome
120. AMP-activated protein kinase α1-sensitive activation of AP-1 in cardiomyocytes
121. Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial
122. Update on Myocarditis and Inflammatory Cardiomyopathy: Reemergence of Endomyocardial Biopsy
123. Cardiac Arrhythmias
124. Plasma mid-regional pro-adrenomedullin levels are inversely associated with anxiety but unrelated to depression: Results from the observational DIAST-CHF study in patients with cardiovascular risk factors
125. Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium: GLP-1R mediated effects in human myocardium
126. Characterization of Myocardial Microstructure and Function in an Experimental Model of Isolated Subendocardial Damage
127. Rationale and Design of the VITALITY-HFpEF Trial
128. Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome: Results From the International Takotsubo Registry
129. Range Variability in CMR Feature Tracking Multilayer Strain across Different Stages of Heart Failure
130. Left ventricular clefts – incidental finding or pathologic sign of Wilson’s disease?
131. Cardiac power output accurately reflects external cardiac work over a wide range of inotropic states in pigs
132. Effect of comprehensive initial training on the variability of left ventricular measures using fast-SENC cardiac magnetic resonance imaging
133. Strain-encoded cardiac magnetic resonance imaging: a new approach for fast estimation of left ventricular function
134. Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical Trial.
135. Gq-Mediated Arrhythmogenic Signaling Promotes Atrial Fibrillation
136. Reduced functional capacity is associated with the proportion of impaired myocardial deformation assessed in heart failure patients by CMR
137. CMR detects decreased myocardial deformation in asymptomatic patients at risk for heart failure
138. Cardiac myocyte alternans in intact heart: Influence of cell–cell coupling and β-adrenergic stimulation
139. Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality risk
140. Homoarginine in Patients With Primary Hyperparathyroidism
141. Magnetic resonance hemodynamic forces predict pathological LVEDP in preserved LV-EF
142. Single center experience of CMR findings after COVID-19 and after COVID-19-vaccination
143. hiPSC derived cardiomyocytes as a tool to test the clinical significance and drug effectiveness in a novel mutation linked to CPVT
144. Phosphorylation of TSC2 serine 1365 protects mice against heart failure with preserved ejection fraction
145. Incremental value of mineralocorticoid receptor antagonists in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
146. Chromogranin B in heart failure with preserved ejection fraction
147. Regional differences in health-related quality of life in elderly heart failure patients: results from the CIBIS-ELD trial
148. Cardiac MRI quantitative tissue characterization of right atrial mass using mDixon and parametric mapping
149. Redefining the role of biomarkers in heart failure trials: expert consensus document
150. Unusual case of ATTR amyloidosis with cardiac manifestation and situs inversus totalis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.